Coloplast A/S

CPSE:COLO B Rapporto sulle azioni

Cap. di mercato: DKK 202.9b

Coloplast Gestione

Gestione criteri di controllo 4/4

Coloplast Il CEO è Kristian Villumsen, nominato in Dec2018, e ha un mandato di 5.92 anni. la retribuzione annua totale è DKK 22.00M, composta da 55.9% di stipendio e 44.1% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.045% delle azioni della società, per un valore di DKK 90.15M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 5.9 anni e 6.8 anni.

Informazioni chiave

Kristian Villumsen

Amministratore delegato

DKK 22.0m

Compenso totale

Percentuale dello stipendio del CEO55.9%
Mandato del CEO5.9yrs
Proprietà del CEO0.04%
Durata media del management5.9yrs
Durata media del Consiglio di amministrazione6.8yrs

Aggiornamenti recenti sulla gestione

Here's Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Looks Fair for the time being

Nov 25
Here's Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Looks Fair for the time being

Recent updates

Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's

Nov 13
Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's

Earnings Update: Coloplast A/S (CPH:COLO B) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts

Nov 08
Earnings Update: Coloplast A/S (CPH:COLO B) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts

Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Oct 18
Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Coloplast A/S Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Aug 23
Coloplast A/S Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Are Investors Undervaluing Coloplast A/S (CPH:COLO B) By 38%?

Aug 22
Are Investors Undervaluing Coloplast A/S (CPH:COLO B) By 38%?

Subdued Growth No Barrier To Coloplast A/S' (CPH:COLO B) Price

Jul 17
Subdued Growth No Barrier To Coloplast A/S' (CPH:COLO B) Price

These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Jun 29
These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Coloplast's (CPH:COLO B) Solid Earnings May Rest On Weak Foundations

May 21
Coloplast's (CPH:COLO B) Solid Earnings May Rest On Weak Foundations

Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of DKK5.00

May 10
Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of DKK5.00

Analyst Estimates: Here's What Brokers Think Of Coloplast A/S (CPH:COLO B) After Its Interim Report

May 09
Analyst Estimates: Here's What Brokers Think Of Coloplast A/S (CPH:COLO B) After Its Interim Report

A Look At The Fair Value Of Coloplast A/S (CPH:COLO B)

Apr 26
A Look At The Fair Value Of Coloplast A/S (CPH:COLO B)

There's Reason For Concern Over Coloplast A/S' (CPH:COLO B) Price

Apr 08
There's Reason For Concern Over Coloplast A/S' (CPH:COLO B) Price

Is Coloplast (CPH:COLO B) A Risky Investment?

Mar 21
Is Coloplast (CPH:COLO B) A Risky Investment?

Estimating The Intrinsic Value Of Coloplast A/S (CPH:COLO B)

Jan 09
Estimating The Intrinsic Value Of Coloplast A/S (CPH:COLO B)

Coloplast A/S' (CPH:COLO B) Price Is Out Of Tune With Earnings

Dec 22
Coloplast A/S' (CPH:COLO B) Price Is Out Of Tune With Earnings

These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Dec 04
These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Coloplast (CPH:COLO B) Strong Profits May Be Masking Some Underlying Issues

Nov 16
Coloplast (CPH:COLO B) Strong Profits May Be Masking Some Underlying Issues

A Look At The Intrinsic Value Of Coloplast A/S (CPH:COLO B)

Sep 30
A Look At The Intrinsic Value Of Coloplast A/S (CPH:COLO B)

Is Coloplast (CPH:COLO B) A Risky Investment?

Jun 28
Is Coloplast (CPH:COLO B) A Risky Investment?

Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 18% Below Its Share Price

Jun 10
Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 18% Below Its Share Price

Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Mar 22
Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly

Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 25% Below Its Share Price

Mar 01
Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 25% Below Its Share Price

These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Dec 14
These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's

Nov 26
Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's

Here's Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Looks Fair for the time being

Nov 25
Here's Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Looks Fair for the time being

Coloplast's (CPH:COLO B) Shareholders Will Receive A Bigger Dividend Than Last Year

Nov 11
Coloplast's (CPH:COLO B) Shareholders Will Receive A Bigger Dividend Than Last Year

With EPS Growth And More, Coloplast (CPH:COLO B) Makes An Interesting Case

Oct 25
With EPS Growth And More, Coloplast (CPH:COLO B) Makes An Interesting Case

Estimating The Fair Value Of Coloplast A/S (CPH:COLO B)

Aug 26
Estimating The Fair Value Of Coloplast A/S (CPH:COLO B)

These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Jul 27
These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well

Here's Why We Think Coloplast (CPH:COLO B) Is Well Worth Watching

Jul 12
Here's Why We Think Coloplast (CPH:COLO B) Is Well Worth Watching

Is There An Opportunity With Coloplast A/S' (CPH:COLO B) 45% Undervaluation?

May 23
Is There An Opportunity With Coloplast A/S' (CPH:COLO B) 45% Undervaluation?

Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of kr.5.00

May 08
Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of kr.5.00

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Kristian Villumsen rispetto agli utili di Coloplast?
DataCompenso totaleStipendioGuadagni aziendali
Sep 30 2024DKK 22mDKK 12m

DKK 5b

Jun 30 2024n/an/a

DKK 5b

Mar 31 2024n/an/a

DKK 5b

Dec 31 2023n/an/a

DKK 5b

Sep 30 2023DKK 23mDKK 12m

DKK 5b

Jun 30 2023n/an/a

DKK 5b

Mar 31 2023n/an/a

DKK 5b

Dec 31 2022n/an/a

DKK 5b

Sep 30 2022DKK 21mDKK 12m

DKK 5b

Jun 30 2022n/an/a

DKK 5b

Mar 31 2022n/an/a

DKK 5b

Dec 31 2021n/an/a

DKK 5b

Sep 30 2021DKK 22mDKK 11m

DKK 5b

Jun 30 2021n/an/a

DKK 5b

Mar 31 2021n/an/a

DKK 4b

Dec 31 2020n/an/a

DKK 4b

Sep 30 2020DKK 20mDKK 11m

DKK 4b

Jun 30 2020n/an/a

DKK 4b

Mar 31 2020n/an/a

DKK 4b

Dec 31 2019n/an/a

DKK 4b

Sep 30 2019DKK 17mDKK 10m

DKK 4b

Jun 30 2019n/an/a

DKK 4b

Mar 31 2019n/an/a

DKK 4b

Dec 31 2018n/an/a

DKK 4b

Sep 30 2018DKK 11mDKK 6m

DKK 4b

Compensazione vs Mercato: La retribuzione totale di Kristian ($USD 3.10M ) è circa la media per le aziende di dimensioni simili nel mercato Danish ($USD 3.68M ).

Compensazione vs guadagni: La retribuzione di Kristian è stata coerente con le performance aziendali dell'ultimo anno.

AMMINISTRATORE DELEGATO

Kristian Villumsen (54 yo)

5.9yrs

Mandato

DKK 22,000,000

Compensazione

Mr. Kristian Villumsen has been Independent Director of Demant A/S since March 5, 2021. He has been the President and Chief Executive Officer of Coloplast A/S since December 4, 2018. Mr. Villumsen was an E...

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Kristian Villumsen
President & CEO5.9yrsDKK 22.00m0.045%
DKK 91.3m
Anders Lonning-Skovgaard
Executive VP & CFO10.3yrsDKK 11.30m0.0012%
DKK 2.4m
Allan Rasmussen
Executive Vice President of Global Operations10.3yrsDKK 9.90m0.011%
DKK 23.0m
Nicolai Andersen
Executive Vice President of Chronic Careno dataDKK 9.50mNessun dato
Paul Marcun
Executive Vice President of Growth5.8yrsDKK 11.50m0.014%
DKK 27.4m
Thomas Barfod
Senior Controller & Employees Representative Directorno dataDKK 450.00k0.000020%
DKK 40.6k
Aleksandra Dimovska
Vice President of Investor Relationsno dataNessun datoNessun dato
Dennis Kaysen
Vice President of Corporate Communicationsno dataNessun datoNessun dato
Dorthe Ronnau
Executive Vice President of People & Culture2.8yrsNessun datoNessun dato
Alain Morvan
Senior Vice President of Sales Europe12.6yrsNessun datoNessun dato
Caroline Rosenstand
Executive Vice President of Voice & Respiratory Careno dataNessun datoNessun dato
Rasmus Møller
Senior Vice President of Wound & Skin Care4.2yrsNessun datoNessun dato

5.9yrs

Durata media

55yo

Età media

Gestione esperta: Il team dirigenziale di COLO B è esperto e expertise (durata media dell'incarico 5.9 anni).

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Thomas Barfod
Senior Controller & Employees Representative Director18.8yrsDKK 450.00k0.000020%
DKK 40.6k
Carsten Hellmann
Independent Director6.9yrsDKK 690.00k0.0027%
DKK 5.4m
Lars Rasmussen
Independent Chairman of the Board5.9yrsDKK 1.84m0.0054%
DKK 10.9m
Niels Louis-Hansen
Deputy Chairman56.8yrsDKK 938.00k1.93%
DKK 3.9b
Marianne Wiinholt
Independent Director3.9yrsDKK 880.00k0.00022%
DKK 446.4k
Jette Nygaard-Andersen
Independent Director8.9yrsDKK 600.00kNessun dato
Nikolaj Gundersen
Employees Representative Director6.8yrsDKK 450.00kNessun dato
Roland Pedersen
Employees Representative Director6.8yrsDKK 450.00k0.00072%
DKK 1.5m
Annette Bruls
Independent Director2.9yrsDKK 600.00kNessun dato

6.8yrs

Durata media

59yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di COLO B sono considerati esperti (durata media dell'incarico 6.8 anni).